S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ORIC Oric Pharmaceuticals Inc

10.77

0.00 (0.00%)

Pre Market

Last Updated: 23:00:03

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Oric Pharmaceuticals (NASDAQ:ORIC)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Oric Pharmaceuticals Charts.

Oric Pharmaceuticals (NASDAQ:ORIC)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Oric Pharmaceuticals Charts.

Oric Pharmaceuticals Inc News

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Tuesday 28 January 2025 (4 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 14 January 2025 (3 weeks ago) • Edgar (US Regulatory)

ORIC® Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones
Tuesday 14 January 2025 (3 weeks ago) • GlobeNewswire Inc.

ORIC Pharmaceuticals Announces Clinical Supply Agreement to Evaluate ORIC-114 in Combination with Amivantamab for the First-Line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations
Tuesday 14 January 2025 (3 weeks ago) • GlobeNewswire Inc.

ORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Tuesday 7 January 2025 (4 weeks ago) • GlobeNewswire Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Saturday 4 January 2025 (4 weeks ago) • GlobeNewswire Inc.

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Tuesday 26 November 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 15 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates
Wednesday 13 November 2024 (3 months ago) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Saturday 9 November 2024 (3 months ago) • Edgar (US Regulatory)

More Oric Pharmaceuticals Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions